Keyphrases
Cost-effectiveness
100%
Low-income
100%
Hispanic
100%
Hepatitis C Treatment
100%
Baby Boomers
100%
Hepatitis C Virus Screening
75%
Medicare
50%
Incremental Cost-effectiveness Ratio
50%
Natural History
25%
Disease Progression
25%
Hepatitis C Virus
25%
Markov Model
25%
Diagnostic Information
25%
Cost Data
25%
Analysis Support
25%
Quality-adjusted Life Years
25%
Drug Costs
25%
Payers
25%
Direct-acting Antivirals
25%
Nursing and Health Professions
Hepatitis C
100%
Cost Effectiveness Analysis
100%
Quality Adjusted Life Year
60%
Medicare
40%
Incremental Cost-Effectiveness Ratio
40%
Diagnosis
20%
Base
20%
Disease Exacerbation
20%
Antiviral Therapy
20%
Drug Cost
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
100%
Hepatitis C
100%
Disease Exacerbation
25%
Base
25%
Antiviral Therapy
25%